Entrepreneur
8 months agoPublic health
Moderna soars on analyst upgrade | Entrepreneur
Moderna saw a 13% stock surge after an analyst upgraded the stock and predicted five product approvals by 2026.
Despite a challenging 2023, Moderna's future growth relies on its diverse pipeline of new products. [ more ]